Gujarat Themis Biosyn’s Rs 3,000 Crore Global Pharma Ambition
Gujarat Themis Biosyn is making a Rs 3,000 crore investment to establish a global pharmaceutical platform, with potential collaborations involving Sanofi and Microbiopharm Japan.
NewsDarpan Editorial Desk


